Literature DB >> 15766307

Assessing demoralization and depression in the setting of medical disease.

Lara Mangelli1, Giovanni A Fava, Silvana Grandi, Luigi Grassi, Fedra Ottolini, Piero Porcelli, Chiara Rafanelli, Marco Rigatelli, Nicoletta Sonino.   

Abstract

OBJECTIVE: The aim of this study was to assess the presence of demoralization and major depression in the setting of medical disease.
METHOD: 807 consecutive outpatients recruited from different medical settings (gastroenterology, cardiology, endocrinology, and oncology) were assessed according to DSM-IV criteria and Diagnostic Criteria for Psychosomatic Research, using semistructured research interviews.
RESULTS: Demoralization was identified in 245 patients (30.4%), while major depression was present in 135 patients (16.7%). Even though there was a considerable overlap between the 2 diagnoses, 59 patients (43.7%) with major depression were not classified as demoralized, and 169 patients (69.0%) with demoralization did not satisfy the criteria for major depression.
CONCLUSIONS: The findings suggest a high prevalence of demoralization in the medically ill and the feasibility of a differentiation between demoralization and depression. Further research may determine whether demoralization, alone or in association with major depression, entails prognostic and clinical implications.

Entities:  

Mesh:

Year:  2005        PMID: 15766307     DOI: 10.4088/jcp.v66n0317

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  21 in total

1.  Differentiation between demoralization, grief, and anhedonic depression.

Authors:  Marcus Wellen
Journal:  Curr Psychiatry Rep       Date:  2010-06       Impact factor: 5.285

Review 2.  Criteria for psychosomatic research (DCPR) in the medical setting.

Authors:  Piero Porcelli; Chiara Rafanelli
Journal:  Curr Psychiatry Rep       Date:  2010-06       Impact factor: 5.285

3.  Demoralization in patients with medical illness.

Authors:  Randy A Sansone; Lori A Sansone
Journal:  Psychiatry (Edgmont)       Date:  2010-08

4.  Gender differences in the long-term associations between posttraumatic stress disorder and depression symptoms: findings from the Detroit Neighborhood Health Study.

Authors:  Danny Horesh; Sarah R Lowe; Sandro Galea; Monica Uddin; Karestan C Koenen
Journal:  Depress Anxiety       Date:  2014-07-10       Impact factor: 6.505

5.  Demoralization syndrome among cancer outpatients in Taiwan.

Authors:  Cheng-Yang Lee; Chun-Kai Fang; Yuh-Cheng Yang; Chien-Liang Liu; Yi-Shing Leu; Tsang-En Wang; Yi-Fang Chang; Ruey-Kuen Hsieh; Yu-Jen Chen; Li-Yun Tsai; Shen-Ing Liu; Hong-Wen Chen
Journal:  Support Care Cancer       Date:  2011-11-27       Impact factor: 3.603

6.  Prevalence of psychiatric disorders across Latino subgroups in the United States.

Authors:  Margarita Alegría; Norah Mulvaney-Day; Maria Torres; Antonio Polo; Zhun Cao; Glorisa Canino
Journal:  Am J Public Health       Date:  2006-11-30       Impact factor: 9.308

7.  Patterns of symptom onset and remission in episodes of hopelessness depression.

Authors:  Brian M Iacoviello; Lauren B Alloy; Lyn Y Abramson; Jimmy Y Choi; Julia E Morgan
Journal:  Depress Anxiety       Date:  2013-03-11       Impact factor: 6.505

8.  Demoralization in Parkinson disease.

Authors:  Brian B Koo; Christopher A Chow; Divya R Shah; Farhan H Khan; Brittani Steinberg; Danielle Derlein; Keerthana Nalamada; Kiran Sai Para; Vikramjeet M Kakade; Amar S Patel; John M de Figueiredo; Elan D Louis
Journal:  Neurology       Date:  2018-04-04       Impact factor: 9.910

9.  Socio-demographic and clinical features associated with demoralization in medically ill in-patients.

Authors:  Carlo Marchesi; Carlo Maggini
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2007-07-11       Impact factor: 4.328

10.  Adult ADHD and comorbid depression: A consensus-derived diagnostic algorithm for ADHD.

Authors:  Diane McIntosh; Stan Kutcher; Carin Binder; Anthony Levitt; Angelo Fallu; Michael Rosenbluth
Journal:  Neuropsychiatr Dis Treat       Date:  2009-04-08       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.